欧蛋白通过调节氧化,血管和亡途径,减轻大鼠辐射诱导的神经退行
Umit Kara1, Ozlem Ozmen2, Okan Sancer3
1Vocational School of Health Services, Medical Imaging Department, Suleyman Demirel University, Isparta, Türkiye.
Molecular nutrition & food research
|August 1, 2025
概括
欧蛋白 (OLE) 通过减少氧化应激,亡和血管变化来保护大脑免受辐射损伤 (RAD). 这种天然化合物有望减轻放射治疗期间中枢神经系统的副作用.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 放射治疗在癌症治疗中至关重要,但可能导致严重的脑损伤.
- 非再生的大脑组织特别容易受到辐射引起的损伤.
- 氧化应激,亡和血管功能障碍是辐射脑损伤的关键机制.
研究的目的:
- 为了研究oleuropein (OLE) 在大鼠模型中对辐射诱导的大脑损伤的神经保护潜力.
- 评估OLE对氧化应激,亡和辐射后血管反应的影响.
- 确定OLE是否可以作为辅助疗法来减少与辐射相关的中枢神经系统 (CNS) 副作用.
主要方法:
- 32只Wistar大鼠被分为对照组,辐射组 (RAD),RAD+OLE和单独的OLE组.
- 进行了组织病理学,免疫组织化学 (Cyclin-D1,CD31,GLUT-1),生物化学 (CK-BB) 和分子 (Bax,Bcl-2) 分析.
- 在皮照射之前和之后,OLE是口服的.
主要成果:
- 辐射暴露导致神经元损伤,亡标记物 (Bax) 增加,抗亡标记物 (Bcl-2) 减少,血管标记物 (Cyclin-D1,CD31,GLUT-1) 和CK-BB.升高.
- OLE治疗显著扭转了这些辐射诱导的变化,保留了大脑组织.
- OLE的使用使生物化学和分子标记正常化,表明氧化应激和亡减少.
结论:
- 欧蛋白 (OLE) 在老鼠中显示出显著的神经保护作用,防止辐射诱导的脑损伤.
- 通过减少氧化应激,亡和异常血管反应,OLE可以减轻损伤.
- 在放射治疗患者中,OLE显示出作为辅助疗法的潜力,以最大限度地减少中枢神经系统的毒性.
相关概念视频
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Biological Effects of Radiation
16.0K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
451
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
451


